Skip Navigation
Multi Photo Banner
Bio Photo

Nadarajah Vigneswaran, BDS, DMD, Dr Med Dent


Title: Professor
Office: BBS-5320
Phone: 713-486-4410
Email: Nadarajah.Vigneswaran@uth.tmc.edu
Department/Administrative Area: Oral Pathology Diagnostics, Diagnostic and Biomedical Sciences


Nadarajah Vigneswaran, BDS, DMD, Dr.Med.Dent. is a Professor at the Department of Diagnostic Sciences, the University of Texas School of Dentistry at Houston. He received his Bachelor of Dental Surgery Degree (BDS) from the University of Peradeniya, Sri Lanka and his DMD degree from the University Of Alabama School Of Dentistry at Birmingham. He obtained his Dr.Med.Dent degree in immunopathology from the University Erlangen, Germany. He completed his three-year Oral and Maxillofacial Pathology Residency at Emory University and a one-year Fellowship in Oral and Maxillofacial Pathology and Oral Oncology at the University of Alabama at Birmingham. Dr. Vigneswaran is licensed by the States of Texas and Alabama to practice dentistry. He is a Fellow of the American Academy of Oral and Maxillofacial Pathology and Diplomate of the American Board of Oral and Maxillofacial Pathology. Dr. Vigneswaran practices surgical and clinical Oral Pathology at the University of Texas School of Dentistry at Houston. He is the Course Director for the School of Dentistry’s Systemic Pathology Course and was awarded the Dean’s Teaching Excellence Award twice.

Dr. Vigneswaran conducts clinical, translational, and basic research in oral precancers and cancers. He is currently involved in several collaborative clinical research projects with scientists and clinicians from Rice University, UT-M.D. Anderson Cancer Center and UTHSC-San Antonio focusing on the development and characterization of novel non-invasive diagnostic devices and chemoprevention agents for oral precancer and cancer. He has an active basic science research focusing on the development of novel animal models, methods and strategies to study oral cancer development and metastasis. His current basic research involves (1) Therapeutic delivery of siRNA to a mouse model of oral cancer and (2) Characterization oral precancer and cancer-specific microRNA signatures using a mouse model of oral tongue carcinogenesis. His current research efforts are funded through the National Institutes of Health and Cancer Prevention and Research Institute of Texas. Dr. Vigneswaran has published more than 75 research articles and clinical reports in highly reputable journals. He has co-authored three book chapters, one in a medical textbook entitled “Vasculitis.